New test could help doctors pick the best antibiotic for UTIs faster
NCT ID NCT07189429
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new system (PA-100 AST) to help doctors quickly choose the right antibiotic for women with urinary tract infections (UTIs). About 199 non-pregnant women with UTI symptoms provided urine samples, which were tested with the new system. The goal was to see if using this system changed how doctors prescribed antibiotics compared to their usual practice. The study focused on improving treatment and reducing antibiotic resistance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
199 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Aug 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients were recruited according to the following criteria: non-pregnant female, \>18 years old, presenting with acute UTI symptoms that had been present for \< 7 days (symptoms according to the current guidelines \[EAU\]), with no antibiotic treatment within the previous 7 days, positive urine dipstick for leukocyte esterase (LEU) and/or nitrites (NIT) and who provided a clean-catch mid-stream urine sample. Exclusion Criteria: Withdraw of consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMR are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro de Salud Ensanche de Vallecas
Madrid, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smarter urine test? new biomarkers aim to end UTI guesswork
- Does the setting of care affect whether kids finish their antibiotics?
- Singapore tests new hospital model to cut stays for acutely ill seniors
- Nine-Year checkup: did a simple catheter care bundle keep preventing infections?
- 500 patients join 5-Year quest to solve UTI mysteries
- Simple tools aim to curb antibiotic overuse in kyrgyzstan